All participants
(N=20)
Number of participants with TEAEs 20 (100%)
Number of participants with Treatment-Related TEAEs* 17 (85%)
Number of participants with Moderate or Severe TEAEs 9 (45%)
Number of participants with Treatment-Related*, Moderate or Severe TEAEs 7 (35%)
Number of Treatment-Emergent Adverse Events 249
Number of Treatment-Related* TEAEs 176
Number of Moderate or Severe TEAEs 22
Number of Treatment-Related*, Moderate or Severe TEAEs 12
Number of TEAE per participant 12.45
Number of Treatment-Related* TEAEs per participant 8.8
Number of Moderate or Severe TEAEs per participant 1.1
Number of Treatment-Related*, Moderate or Severe TEAEs per participant 0.6